Freemer; Michelle
Patent Applications and Registrations
Patent applications and USPTO patent grants for Freemer; Michelle.The latest application filed is for "diagnosis and treatments relating to th2 inhibition".
- Freemer; Michelle - Mill Valley CA
| Patent | Date |
|---|---|
| Method of treating asthma using an IL-13 antibody Grant 11,226,341 - Arron , et al. January 18, 2 | 2022-01-18 |
| Diagnosis And Treatments Relating To Th2 Inhibition App 20190120854 - Arron; Joseph R. ; et al. | 2019-04-25 |
| Diagnosis and treatments relating to TH2 inhibition Grant 9,995,755 - Arron , et al. June 12, 2 | 2018-06-12 |
| Diagnosis and treatments relating to TH2 inhibition Grant 9,684,000 - Arron , et al. June 20, 2 | 2017-06-20 |
| Diagnosis And Treatments Relating To Th2 Inhibition App 20140044645 - Arron; Joseph R. ; et al. | 2014-02-13 |
| Diagnosis And Treatments Relating To Th2 Inhibition App 20140044702 - Arron; Joseph R. ; et al. | 2014-02-13 |
| Diagnosis And Treatments Relating To Th2 Inhibition App 20120156194 - Arron; Joseph R. ; et al. | 2012-06-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 